IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Sands Capital Alternatives, LLC

Q4 2021 Holdings

Filed 2022-01-21 | 16 holdings | $30.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Acumen Pharmaceuticals, Inc(ABOS)COM00509G209$23.1M3,417,07575.6%
Candel Therapeutics, Inc(CADL)COM137404109$6.3M811,73720.8%
Absci Corp.(ABSI)COM00091E109$474.0K57,8041.6%
Uipath Inc(PATH)COM CL A90364P105$164.4K3,811,7790.5%
Doordash Inc(DASH)COM CL A25809K105$89.6K601,4540.3%
NU Holdings Ltd.(NU)COM CL AG6683N103$85.7K9,136,8350.3%
Dice Therapeutics, Inc.COM23345J104$79.7K3,148,9700.3%
Samsara, Inc.COM CL BFDS1Q2O30$76.2K2,712,2560.2%
Snowflake Inc(SNOW)COM CL A833445109$72.7K214,6210.2%
Karuna Therapeutics, Inc.COM48576A100$35.1K267,8950.1%
Samsara, Inc.(IOT)COM CL A79589L106$9.2K326,0000.0%
908 Devices Inc(MASS)COM65443P102$8.4K326,4270.0%
Taysha Gene Therapies Inc(TSHA)COM877619106$8.4K724,8730.0%
Repligen Corp.(RGEN)COM759916109$6.0K22,5440.0%
Tarsus Pharmaceuticals Inc(TARS)COM87650L103$5.9K260,0000.0%
Spruce Biosciences IncCOM85209E109$3.5K787,0070.0%